The Patient Derived Xenograft- PDX Models Market size is expected to grow at an annual average CAGR of 15% during 2022-2028. Patient-derived xenografts (PDX) are cancer models in which tumor tissue or cells from a patient are transplanted into immunodeficient or humanized mice. The PDX model simulates human tumor biology allowing spontaneous cancer progression and […]
Tag Archives: Patient-Derived Xenograft (PDX) Models Market
The Global Patient-Derived Xenograft (PDX) Models Market size is projected to reach USD 299 million by 2028 from USD 140 million in 2021, at a CAGR of 16% during the forecast period 2022-2028. Patient-derived xenografts (PDX) are cancer models in which tumor tissue or cells from a patient are transplanted into immunodeficient or humanized mice. […]